A detailed history of Avoro Capital Advisors LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 12,345,678 shares of AUTL stock, worth $36.3 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
12,345,678
Previous 12,345,678 -0.0%
Holding current value
$36.3 Million
Previous $43 Million 4.31%
% of portfolio
0.67%
Previous 0.59%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.39 - $7.29 $66.5 Million - $90 Million
12,345,678 New
12,345,678 $78.8 Million

Others Institutions Holding AUTL

About Autolus Therapeutics plc


  • Ticker AUTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,909,800
  • Market Cap $267M
  • Description
  • Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...
More about AUTL
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.